Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Tumors 1 Lung Neoplasms 1 Glioblastoma 1 Colorectal Neoplasms 1

Interventions

Carboplatin 18 Radiotherapy 10 Cisplatin 10 Pemetrexed 8 Paclitaxel 8 durvalumab 6 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 Radiosurgery 5 Nivolumab 5 Etoposide 5 pembrolizumab 4 atezolizumab 4 Surveys and Questionnaires 4 Radiation 4 Erlotinib Hydrochloride 4 Docetaxel 4 Taxes 3 Standard of Care 3 Specimen Handling 3 Platinum 3 Cetuximab 3 Bronchoscopy 3 Biopsy 3 Bevacizumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 sapanisertib 2 etoposide phosphate 2 capmatinib 2 Vinorelbine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lung Neoplasms × Tiragolumab × Clear all

NCT06713798 2026-03-23

INDIGO

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Withdrawn

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡